Fludarabine therapy in a patient with progressive symptomatic Waldenström's macroglobulinemia.
A 66-year old female patient with symptomatic Waldenström's macroglobulinemia was treated with six courses of fludarabine monophosphate, which resulted in partial remission of the disease. Six months after completion of therapy IgM level decreased further and durable partial remission was confirmed.
Hałaburda
K
K
Department of Hematology, University Medical School, Gdańsk.
Hellmann
A
A
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D008875:Middle Aged; D012074:Remission Induction; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008258:Waldenstrom Macroglobulinemia / Q000097:blood / Q000188:drug therapy*
D000970:Antineoplastic Agents; D006454:Hemoglobins; D007075:Immunoglobulin M; D014740:Vidarabine; C024352:fludarabine